DULUTH, Ga., Oct. 24, 2024 /PRNewswire/ -- Boehringer Ingelheim announced the grand opening of its newly expanded research and development facility in Athens, Georgia. As the largest animal ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals ...

"Our new research and development facility in Athens marks a significant milestone ... U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent ...

Boehringer Ingelheim announced the grand opening of its newly expanded research and development facility in Athens, Georgia. As the largest animal health company in Georgia, this Boehringer state ...

This expansion was made possible through collaboration with the Georgia Department of Economic Development, Invest Athens, Metro Atlanta Chamber, and Georgia Power. About Boehringer Ingelheim ...

Grand Opening of State-of-the-Art Research and Development Facility "Our new research and development facility in Athens marks ... Managing Director at Boehringer Ingelheim.

Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure sustainable patient access to Boehringer Ingelheim’s portfolio of leading ...

With a capital investment of US$66.1 million and 63 new jobs created, this expansion includes the addition of 63,000 square feet of administrative space and more than 28,000 square feet of laboratory ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...